Synthesis of New Chromene Derivatives Targeting Triple-Negative Breast Cancer Cells.
apoptosis
chromenes
microtubules
mitotic slippage
multinucleation
senescence
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
09 May 2023
09 May 2023
Historique:
received:
01
03
2023
revised:
10
04
2023
accepted:
06
05
2023
medline:
22
6
2023
pubmed:
22
6
2023
entrez:
22
6
2023
Statut:
epublish
Résumé
Breast cancer continues to be the leading cause of cancer-related deaths among women worldwide. The most aggressive type of breast cancer is triple-negative breast cancer (TNBC). Indeed, not only does TNBC not respond well to several chemotherapeutic agents, but it also frequently develops resistance to various anti-cancer drugs, including taxane mitotic inhibitors. This necessitates the search for newer, more efficacious drugs. In this study, we synthesized two novel chromene derivatives (
Identifiants
pubmed: 37345018
pii: cancers15102682
doi: 10.3390/cancers15102682
pmc: PMC10216081
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Bioorg Med Chem Lett. 2012 Jul 1;22(13):4458-61
pubmed: 22608389
Am J Pathol. 2017 Oct;187(10):2139-2151
pubmed: 28736315
Bioorg Med Chem. 2016 Mar 15;24(6):1292-7
pubmed: 26867486
Oncologist. 2014 Oct;19(10):1076-83
pubmed: 25142841
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Int J Mol Sci. 2022 Jun 20;23(12):
pubmed: 35743305
Cell Cycle. 2014;13(11):1756-64
pubmed: 24694730
Cytoskeleton (Hoboken). 2010 Oct;67(10):630-4
pubmed: 20737541
Eur J Pharm Sci. 2015 May 25;72:34-45
pubmed: 25746954
IUBMB Life. 2015 Jun;67(6):395-403
pubmed: 26104829
Front Pharmacol. 2018 Mar 22;9:245
pubmed: 29623040
Anticancer Agents Med Chem. 2009 May;9(4):437-56
pubmed: 19442043
Oncotarget. 2018 May 22;9(39):25545-25556
pubmed: 29876007
J Hematol Oncol. 2019 Nov 26;12(1):123
pubmed: 31771633
Oncotarget. 2017 May 2;8(40):67017-67028
pubmed: 28978013
Br J Clin Pharmacol. 2017 Feb;83(2):255-268
pubmed: 27620987
Curr Cancer Drug Targets. 2007 Sep;7(6):566-81
pubmed: 17896922
Med Chem. 2011 Sep;7(5):466-72
pubmed: 21801146
Endocr Relat Cancer. 2017 Sep;24(9):T97-T106
pubmed: 28684541
Biochim Biophys Acta. 2013 Apr;1830(4):3121-35
pubmed: 23352703
Eur J Cell Biol. 2020 May;99(4):151075
pubmed: 32414588
Proc Natl Acad Sci U S A. 2021 Jun 1;118(22):
pubmed: 34031242
Cancer Res. 2008 May 1;68(9):3269-76
pubmed: 18451153
Eur J Med Chem. 2018 Sep 5;157:101-114
pubmed: 30081238
Mol Cancer Ther. 2013 Dec;12(12):2837-46
pubmed: 24107446
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Mol Cancer Ther. 2006 Sep;5(9):2348-57
pubmed: 16985069
J Vasc Res. 2011;48(5):369-85
pubmed: 21464572
Breast Cancer Res Treat. 2002 Nov;76(2):157-66
pubmed: 12452453
Bioorg Med Chem Lett. 2020 Sep 1;30(17):127410
pubmed: 32738990
Traffic. 2004 Jul;5(7):470-7
pubmed: 15180824
Pharm Res. 2012 Nov;29(11):2943-71
pubmed: 22814904
Front Chem. 2020 Aug 05;8:623
pubmed: 32850645
Exp Cell Res. 1994 Jun;212(2):201-8
pubmed: 7910561
J Asian Nat Prod Res. 2010 Nov;12(11):992-1000
pubmed: 21061222
Breast Cancer Res Treat. 2020 Aug;182(3):643-654
pubmed: 32524352
Carcinogenesis. 1990 Sep;11(9):1557-61
pubmed: 2169356
Annu Rev Biophys. 2011;40:169-86
pubmed: 21314430
Future Med Chem. 2013 Sep;5(14):1647-60
pubmed: 24047270
Mol Ther Oncolytics. 2021 Feb 24;20:596-606
pubmed: 33768141
Biology (Basel). 2020 Nov 07;9(11):
pubmed: 33171868
Clin Cancer Res. 2001 Aug;7(8):2573-80
pubmed: 11489841
Nat Struct Mol Biol. 2012 Mar 11;19(4):387-94
pubmed: 22407014
Breast. 2022 Dec;66:15-23
pubmed: 36084384
Semin Immunol. 2018 Dec;40:101275
pubmed: 31088710
BMC Cancer. 2007 Nov 20;7:216
pubmed: 18021457
Nat Commun. 2017 Sep 14;8(1):542
pubmed: 28912485
J Cancer. 2021 Jan 1;12(1):270-280
pubmed: 33391424
Front Oncol. 2019 Aug 21;9:795
pubmed: 31497536
J Cell Commun Signal. 2020 Mar;14(1):77-91
pubmed: 31493173
J Med Chem. 2004 Dec 2;47(25):6299-310
pubmed: 15566300
Cell Rep. 2015 Sep 1;12(9):1483-96
pubmed: 26299965
World J Clin Oncol. 2015 Dec 10;6(6):252-63
pubmed: 26677438
Clin Med Insights Oncol. 2018 Jul 27;12:1179554918790563
pubmed: 30083066
Commun Biol. 2021 Apr 9;4(1):451
pubmed: 33837239
Comp Biochem Physiol C Toxicol Pharmacol. 2000 Jan;125(1):121-31
pubmed: 11790336
Mol Cell Biol. 1999 Mar;19(3):2109-17
pubmed: 10022898
Mol Carcinog. 2008 Dec;47(12):905-15
pubmed: 18314876
Drug Discov Today. 2022 Mar;27(3):759-776
pubmed: 34890803
Curr Drug Targets. 2019;20(7):705-715
pubmed: 30556499